| http://www.w3.org/ns/prov#value | - s, fasting plasma glucose (IFG), metabolic acidosis, ketosis, appetite regulation, obesity, immunosuppressants or cytokine release regulation, autoimmune diseases such as inflammatory bowel disease, multiple sclerosis and arthritisUS7696161May 25, 2007Apr 13, 2010Amylin Pharmaceuticals, Inc.Exendin agonist compoundsUS7700549Aug 29, 2008Apr 20, 2010Amylin Pharmaceuticals, Inc.treating Type II diabe
|
